Page last updated: 2024-08-24

simendan and Ischemia

simendan has been researched along with Ischemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Boening, A; Heep, M; Hemmerich, C; Niemann, B; Schlüter, KD; Taghiyev, ZT; Welk, E1
Aalto-Setälä, K; Gaballah, M; Kallio, P; Kreutzer, J; Mäki, AJ; Penttinen, K1
Abrass, CK; Hanson, SY; Johnson, AC; Lund, S; Zager, RA1
Beiras-Fernandez, A; Fuchs, H; Meiser, BM; Reichart, B; Weis, FC; Weis, M1
Andrade, AC; Mebazaa, A; Tavares, M1

Reviews

1 review(s) available for simendan and Ischemia

ArticleYear
Levosimendan use in several scenarios of acute heart failure.
    Arquivos brasileiros de cardiologia, 2008, Volume: 90, Issue:3

    Topics: Acute Disease; Adrenergic beta-Antagonists; Cardiotonic Agents; Contraindications; Heart Failure; Hemodynamics; Humans; Hydrazones; Hypotension; Ischemia; Phosphodiesterase Inhibitors; Pyridazines; Simendan; Syndrome; Vasodilator Agents

2008

Other Studies

4 other study(ies) available for simendan and Ischemia

ArticleYear
Oral application of levosimendan before ischaemia/reperfusion with or without cardioplegic arrest in rats.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2022, 09-02, Volume: 62, Issue:4

    Topics: Animals; Calcium; Cardioplegic Solutions; Drinking Water; Heart Arrest; Heart Arrest, Induced; Ischemia; Rats; Reperfusion; Simendan; Sodium Chloride; Troponin I

2022
Cardiac Ischemia On-a-Chip: Antiarrhythmic Effect of Levosimendan on Ischemic Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Cells, 2022, 03-19, Volume: 11, Issue:6

    Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cells, Cultured; Humans; Hypoxia; Induced Pluripotent Stem Cells; Ischemia; Lab-On-A-Chip Devices; Myocardial Ischemia; Myocytes, Cardiac; Simendan

2022
Levosimendan protects against experimental endotoxemic acute renal failure.
    American journal of physiology. Renal physiology, 2006, Volume: 290, Issue:6

    Topics: Acute Kidney Injury; Adenosine Triphosphate; Animals; Anti-Inflammatory Agents; Cardiotonic Agents; Chemokine CCL2; Endotoxemia; Glyburide; Hydrazones; Inflammation; Ischemia; Kidney; Lipopolysaccharides; Male; Mesangial Cells; Mice; Nitric Oxide; Potassium Channel Blockers; Potassium Channels; Pyridazines; Simendan; Tumor Necrosis Factor-alpha

2006
Levosimendan treatment after primary organ failure in heart transplantation: a direct way to recovery?
    Transplantation, 2006, Oct-27, Volume: 82, Issue:8

    Topics: Adolescent; Aged; Calcium; Cardiomyopathies; Catecholamines; Female; Heart; Heart Transplantation; Humans; Hydrazones; Ischemia; Male; Phosphodiesterase Inhibitors; Pyridazines; Simendan

2006